Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Phase 3 Completed
1,501 enrolled 16 charts
Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy
Phase 2 Completed
26 enrolled 14 charts
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
Phase 2 Completed
87 enrolled 11 charts
SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Phase 2 Completed
30 enrolled 13 charts
Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Phase 2/3 Completed
500 enrolled
Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
Phase 3 Completed
600 enrolled
Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer
Phase 2 Completed
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase 3 Completed
Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma
Phase 3 Completed
840 enrolled
Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 3 Completed
Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer
Phase 3 Completed
Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer
Phase 2 Completed
56 enrolled
Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Phase 2 Completed
90 enrolled
Vinorelbine and XR9576 to Treat Cancer
Phase 1 Completed
30 enrolled